Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
Authors:
- Julianne GeeJGJulianne Gee
- Allison NalewayANAllison Naleway
- Irene ShuiISIrene Shui
- James BaggsJBJames Baggs
- Ruihua YinRYRuihua Yin
- Rong LiRLRong Li
- Martin KulldorffMKMartin Kulldorff
- Edwin LewisELEdwin Lewis
- Bruce FiremanBFBruce Fireman
- Matthew F. DaleyMDMatthew F. Daley
- Nicola P. KleinNKNicola P. Klein
- Eric S. WeintraubEWEric S. Weintraub
- 1 October 2011
- Vol. 29 (46) , 8279-8284
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
This publication has 20 references indexed in Scilit:
- Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink ProjectPediatrics, 2011
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety SurveillanceSequential Analysis, 2011
- Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety dataVaccine, 2011
- Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile SeizuresPediatrics, 2010
- Influenza Vaccination and Mortality: Differentiating Vaccine Effects From BiasAmerican Journal of Epidemiology, 2009
- Anaphylaxis following quadrivalent human papillomavirus vaccinationCanadian Medical Association Journal, 2008
- An Algorithm for Treatment of Patients With Hypersensitivity Reactions After VaccinesPediatrics, 2008
- Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse EventsMedical Care, 2007
- The worcester venous thromboembolism studyJournal of General Internal Medicine, 2006
- A spatial scan statisticCommunications in Statistics - Theory and Methods, 1997